In one paragraphArticle in Journal of clinical medicine research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
13 authors.
Anna BraginaDepartment of Internal Medicine No. 2, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenovskiy University), Moscow, Russia.ORCID https://orcid.org/0000-0002-2699-1610 Aida TarzimanovaDepartment of Internal Medicine No. 2, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenovskiy University), Moscow, Russia.ORCID https://orcid.org/0000-0001-9536-8307 Yulia RodionovaDepartment of Internal Medicine No. 2, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenovskiy University), Moscow, Russia.ORCID https://orcid.org/0000-0003-3461-6703 Konstantin OsadchiyDepartment of Internal Medicine No. 2, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenovskiy University), Moscow, Russia.ORCID https://orcid.org/0000-0001-8202-4492 Tatiana IshinaDepartment of Internal Medicine No. 2, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenovskiy University), Moscow, Russia.ORCID https://orcid.org/0000-0001-7720-0770 Ivan MedvedevDepartment of Internal Medicine No. 2, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenovskiy University), Moscow, Russia.ORCID https://orcid.org/0000-0003-4210-2841 Lubov VasilevaDepartment of Internal Medicine No. 2, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenovskiy University), Moscow, Russia.ORCID https://orcid.org/0000-0001-5730-7837 Natalia DruzhininaDepartment of Internal Medicine No. 2, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenovskiy University), Moscow, Russia.ORCID https://orcid.org/0000-0001-8397-0210 Karina UmbetovaDepartment of Infectious Diseases, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenovskiy University), Moscow, Russia.ORCID https://orcid.org/0000-0003-0902-9267 Olga BelayaDepartment of Infectious Diseases, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenovskiy University), Moscow, Russia.ORCID https://orcid.org/0000-0002-2722-1335 Maria KutushevaDepartment of Internal Medicine No. 2, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenovskiy University), Moscow, Russia.ORCID https://orcid.org/0009-0002-3850-4987 Zlata NefedovaDepartment of Internal Medicine No. 2, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenovskiy University), Moscow, Russia.ORCID https://orcid.org/0009-0007-0727-3297 Valery PodzolkovDepartment of Internal Medicine No. 2, Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenovskiy University), Moscow, Russia.ORCID https://orcid.org/0000-0002-0758-5609 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Background: Coronavirus disease 2019 (COVID-19) and obesity remain pressing global health concerns. Identifying predictors of severe disease is of particular importance. Pericardial fat tissue (PFT) is a known source of metainflammation due to its secretion of adipocytokines and inflammatory mediators. Moreover, cytokine storm plays a major role in COVID-19-related mortality. This study aimed to investigate the association between preexisting PFT volume and inflammatory markers in patients with COVID-19. Methods: The study included 290 hospitalized patients with confirmed COVID-19 infection. Based on PFT volume (above or below 3.45 cm Results: Significant intergroup differences were observed in the PO group for the following variables: male sex (P < 0.001), body mass index (BMI) (P < 0.001), obesity (P < 0.001), and history of diabetes mellitus (P = 0.003). No significant differences were found in lung computed tomography (CT) severity scores. However, patients with PO showed significantly lower oxygen saturation (SpO Conclusions: Our data suggest that a PFT volume greater than 3.45 cm
Indexed as
COVID-19InflammationObesityPericardial fat tissueSARS-CoV-2 infection
Identifiers
PMID41209576
PMCPMC12591241
What Socratic holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390